SICAGEN INDIA LTD. - 533014 - Closure of Trading Window
Intimation of closure of Trading Window for dealing in Company's securities by the Designated persons and their immediate relatives from April 01, 2022 till 48 hours after the declaration of Audited Financial Results for the quarter and year ending March 31, 2022 is submitted. We request you to kindly take the above on record. SICAGEN INDIA LTD. - 533014 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding Loss of Share Certificate(s) SICAGEN INDIA LTD. - 533014 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement
The Board of Directors of the Company at its meeting held on 11.02.2022 has inter alia, considered and approved a draft Scheme of Amalgamation of wholly owned subsidiary Company M/s. Danish Steel Cluster Pvt Ltd with M/s. Sicagen India Limited. Pursuant to Regulation 37 of SEBI (LODR) Regulations 2015, a copy of draft Scheme of Amalgamation is submitted herewith. SICAGEN INDIA LTD. - 533014 - Board Meeting Outcome for Submission Of Unaudited Financial Results Of The Company And Limited Review Report For The Quarter And Nine Months Ended 31St December 2021
The Board of Directors of the Company at its meeting held on 11.02.2022 has inter alia, considered and approved the unaudited financial results of the Company for the quarter and nine months ended 31st December 2021. Pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, the aforesaid financial results together with the limited review report of statutory auditors are submitted herewith. SICAGEN INDIA LTD. - 533014 - Board Meeting Intimation for Considering Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2021.
SICAGEN INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2022 ,inter alia, to consider and approve the unaudited financial results of the company for the quarter and nine months ended 31st December 2021. SICAGEN INDIA LTD. - 533014 - Shareholding for the Period Ended December 31, 2021
Sicagen India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here SICAGEN INDIA LTD. - 533014 - Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- S Ankita SharmaDesignation :- Company Secretary and Compliance Officer SICAGEN INDIA LTD. - 533014 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We herewith submit the copy of compliance certificate as required under Reg 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31/12/2021. SICAGEN INDIA LTD. - 533014 - Intimation - Relocation Of Speciality Chemicals Manufacturing Unit
The manufacturing unit of speciality chemicals division of the Company situated at Thirubuvanai, Pondicherry has been re-located to Tuticorin. Necessary intimation with regard to shifting of above unit has been given to the appropriate authorities in this regard. Sicagen India Ltd - 533014 - Appointment of Company Secretary and Compliance Officer
The Board of Directors of the Company at its meeting held today, has considered and appointed Ms. S. Ankita Sharma as Company Secretary & Compliance Officer of the Company w.e.f. 01st December 2021 as recommended by the Nomination & Remuneration Committee. Ms. S Ankita Sharma, aged about 27 years, is a qualified Company Secretary (ACS) and having 3 years of work experience in corporate secretarial functions. The above information may kindly be taken on record.